Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Investcafe
$23.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Farmstandart OAO Announces Further Details On Planned Acquisition Of Lekko-PRIME


Thursday, 25 Oct 2012 09:28am EDT 

PRIME reported that Farmstandart OAO (Pharmstandard) will spend up to $25 million to buy pharmaceutical producer Lekko, according to the Company's Chief Financial Officer Ms. Yelena Arkhangelskaya. The Company has planned to allocate no more than $100 million towards merger and acquisitions deals for 2012. It has already spent $60 million. But it now sees that this amount will not exceed $80 million, and $20–25 million will be directed to Lekko, Ms. Arkhangelskaya said. She confirmed the Company’s intention to close the deal by the end of 2012. Pharmstandard has permission from the Federal Antimonopoly Service to purchase Lekko. 

Company Quote

1259.2
13.9 +1.12%
11 Jul 2014